UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

The New England journal of medicine, 2023-08, Vol.389 (8), p.710-721

2023

Volltextzugriff (PDF)

Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.243-246

2018

Volltextzugriff (PDF)

Sprouty genes function in suppression of prostate tumorigenesis

Proceedings of the National Academy of Sciences - PNAS, 2012-12, Vol.109 (49), p.20023-20028

2012

Volltextzugriff (PDF)

Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors

Clinical cancer research, 2024-09, Vol.30 (17), p.3788-3797

2024

Volltextzugriff (PDF)

“You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs

BMC public health, 2020-06, Vol.20 (1), p.1-1016, Article 1016

2020

Volltextzugriff (PDF)

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

NPJ precision oncology, 2022-12, Vol.6 (1), p.91-91, Article 91

2022

Volltextzugriff (PDF)

Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors

Clinical cancer research, 2017-05, Vol.23 (10), p.2423-2432

2017

Volltextzugriff (PDF)

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer

European journal of cancer (1990), 2017-11, Vol.86, p.186-196

2017

Volltextzugriff (PDF)

Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC

NPJ precision oncology, 2024-07, Vol.8 (1), p.153-11, Article 153

2024

Volltextzugriff (PDF)

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors

The oncologist (Dayton, Ohio), 2017-12, Vol.22 (12), p.1491-1499

2017

Volltextzugriff (PDF)

New insights into the genetic etiology of Alzheimer's disease and related dementias

Nature genetics, 2022, Vol.54 (4), p.412-436

2022

Volltextzugriff (PDF)

Soc-2 Encodes a Leucine-Rich Repeat Protein Implicated in Fibroblast Growth Factor Receptor Signaling

Proceedings of the National Academy of Sciences - PNAS, 1998-06, Vol.95 (12), p.6903-6908

1998

Volltextzugriff (PDF)

Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries

Nature communications, 2021-02, Vol.12 (1), p.1258-1258, Article 1258

2021

Volltextzugriff (PDF)

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

Nature medicine, 2020-04, Vol.26 (4), p.549-557

2020

Volltextzugriff (PDF)

Abstract 29: Utility of novel clinico-genomic data to understand patient characteristics, treatments, and outcomes according to PIK3CA mutation status among hormone receptor-positive metastatic breast cancer patients

Clinical cancer research, 2020-06, Vol.26 (12_Supplement_1), p.29-29

2020

Volltextzugriff (PDF)

Diverse transposable elements are mobilized in hybrid dysgenesis in Drosophila virilis

Proceedings of the National Academy of Sciences - PNAS, 1995-08, Vol.92 (17), p.8050-8054

1995

Volltextzugriff (PDF)

The role of polygenic risk and susceptibility genes in breast cancer over the course of life

Nature communications, 2020-12, Vol.11 (1), p.6383-6383, Article 6383

2020

Volltextzugriff (PDF)

Genetic architecture of human plasma lipidome and its link to cardiovascular disease

Nature communications, 2019-09, Vol.10 (1), p.4329-4329, Article 4329

2019

Volltextzugriff (PDF)

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

Nature communications, 2023-05, Vol.14 (1), p.2709-2709, Article 2709

2023

Volltextzugriff (PDF)

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1530-1536

2021

Volltextzugriff (PDF)

Abstract OT-36-01: Phase III study of GDC-0077 or placebo (pbo) with palbociclib (P) + fulvestrant (F) in patients with PIK3CA -mutant/hormone receptor-positive/HER2-negative locally advanced or metastatic breast cancer (HR+/HER2- LA/MBC)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-36-01-OT-36-01

2021

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(32)
Humans
(30)
Female
(19)
Male
(15)
Risk Factors
(15)
Middle Aged
(14)
Multidisciplinary Sciences
(13)
Science & Technology - Other Topics
(13)
Genomes
(11)
Aged
(10)
Cancer
(9)
Oncology
(9)
Mutation
(8)
Tumors
(8)
Biochemistry & Molecular Biology
(7)
Genes
(7)
Genetic Predisposition To Disease
(7)
Genome-Wide Association Studies
(7)
Genome-Wide Association Study
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation

Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?

Sprouty genes function in suppression of prostate tumorigenesis

Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer

“You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors

A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non–small cell lung cancer

Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors

New insights into the genetic etiology of Alzheimer's disease and related dementias

Soc-2 Encodes a Leucine-Rich Repeat Protein Implicated in Fibroblast Growth Factor Receptor Signaling

Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection

Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells

Abstract 29: Utility of novel clinico-genomic data to understand patient characteristics, treatments, and outcomes according to PIK3CA mutation status among hormone receptor-positive metastatic breast cancer patients

Diverse transposable elements are mobilized in hybrid dysgenesis in Drosophila virilis

The role of polygenic risk and susceptibility genes in breast cancer over the course of life

Genetic architecture of human plasma lipidome and its link to cardiovascular disease

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers

Abstract OT-36-01: Phase III study of GDC-0077 or placebo (pbo) with palbociclib (P) + fulvestrant (F) in patients with PIK3CA -mutant/hormone receptor-positive/HER2-negative locally advanced or metastatic breast cancer (HR+/HER2- LA/MBC)

Suchergebnisse filtern